肝酶抑制剂改善了败血性心肌病患者的临床研究
Di Chen1, Honglei Li1, Shitao Huang1
1The First Clinical College of Lanzhou University, Lanzhou, Gansu, China.
Frontiers in medicine
|August 22, 2024
概括
低分子量肝素 (LMWH) 治疗显著降低了肝酶 (HPA) 水平,并在性心肌病 (SCM) 患者中改善了心脏功能. 这种干预也降低了炎症和死亡率,这表明LMWH是SCM的有价值的治疗选择.
科学领域:
- 关键护理医学 关键护理医学
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 败血性心肌病 (SCM) 是败血症的严重并发症,死亡率高.
- 目前尚不完全了解SCM的发病因子,缺乏诊断标志物.
- 目前的治疗重点是潜在的败血症和症状管理.
研究的目的:
- 研究低分子量肝素 (LMWH) 对SCM患者肝酶 (HPA) 水平的影响.
- 评估HPA作为SCM的诊断标记物的临床意义.
- 评估LMWH对SCM心脏功能,炎症和死亡率的影响.
主要方法:
- 一项前性随机对照试验,涉及105名SCM患者.
- 患者被分配到对照组 (标准治疗) 或干预组 (标准治疗+LMWH).
- 测量了包括HPA,syndecan-1,炎症标志物,心脏功能指数和临床结果在内的关键参数.
主要成果:
- 与对照组相比,LMWH治疗显著降低了HPA和syndecan-1水平 (p<0.05).
- 在LMWH组显示改善心脏功能 (LVEF,FS,SV,CPI) 和减少炎症标志物 (IL-6,TNF-α).
- ROC分析表明,HPA与NT-proBNP,CTnI和H-FABP相结合可以提高SCM诊断效率.
结论:
- 在SCM管理中整合LMWH有效降低HPA水平并改善心脏功能.
- 在SCM患者中,LMWH治疗减轻炎症,增强免疫功能,改善微循环.
- 这些改善与临床严重性降低,ICU停留时间缩短和28天死亡率降低相关.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
405
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
405
01:26Heart Failure Drugs: Inotropic Agents
545
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
545
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
654
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
654